NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

乳糜瀉市場:2021-2027

Celiac Disease Market 2021-2027

出版商 Orion Market Research Pvt Ltd 商品編碼 1025337
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
乳糜瀉市場:2021-2027 Celiac Disease Market 2021-2027
出版日期: 2021年06月23日內容資訊: 英文
簡介

在預測期內,全球乳糜瀉市場預計將以 8.5% 的複合年增長率增長。市場擴張背後的主要因素是治療產品在新興國家的普及、糖尿病患者的增加、乳糜瀉治療藥物臨床試驗數量的增加以及導致乳糜瀉的麩質消費量增加。是。例如,根據美國疾病控制與預防中心的數據,2020 年美國將有大約 3420 萬糖尿病患者,占美國人口的 10.5%。

此外,在預測期內,醫療領域的技術發展、現代化的擴大和研發活動的增加將為乳糜瀉治療市場帶來新的機遇。由於 COVID-19 大流行期間全球乳糜瀉患者的高風險,全球乳糜瀉市場顯著低迷。乳糜瀉是一種自身免疫性疾病,由各種食物中或添加到各種食物中的蛋白質無法抵抗麩質引起。製造關閉,影響整個供應鏈。

本報告探討了乳糜瀉市場,並按治療類型、診斷類型、最終用戶、地區和進入市場的公司概況介紹了市場概況以及趨勢。

目錄

第 1 章報告概述

第 2 章市場概覽和洞察

  • 調查範圍
  • 分析師洞察和當前市場趨勢

第三章競爭形勢

  • 主要公司分析
    • 概述
    • 財務分析
    • SWOT 分析
  • 重要的戰略分析
  • COVID-19 對主要參與者的影響

第 4 章市場決定因素

  • 增長因素
  • 抑製器
  • 市場機會

第五章市場細分

  • 全球乳糜瀉市場,按治療類型
    • 維生素和飲食(無麩質)補充劑
    • 類固醇和免疫抑製藥物
    • 治療性疫苗
  • 全球乳糜瀉市場,按診斷類型
    • 血清學檢測
    • 基因檢測
    • 小腸活檢
  • 按最終用戶劃分的全球乳糜瀉市場
    • 醫院和診斷中心
    • 研究所

第六章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他
  • 其他領域

第 7 章公司簡介

  • Abbott Laboratories
  • AbbVie Inc.
  • ADMA Biologics, Inc.
  • Amgen Inc.
  • Bayer AG
  • Bio Rad Laboratories, Inc.
  • BioLineRX Ltd.
  • Boston Scientific Corp.
  • Bristol-Myers Squibb Co.
  • Calypso Biotech SA
  • ChemoCentryx, Inc.
  • Eli Lilly And Co.
  • GlaxoSmithKline plc
  • ImmunogenX, Inc.
  • Janssen Pharmaceuticals, Inc.
  • Johnson & Johnson Services Inc.,
  • Merck & Co., Inc.,
  • Sanofi S.A
  • Thermo Fisher Scientific Inc.
  • ZEDIRA GmbH
目錄
Product Code: OMR2023751

Global Celiac Disease Market Size, Share & Trends Analysis Report by Treatment Type (Vitamins and Dietary (Gluten-Free) Supplements, Steroids and Immunosuppressive Drugs, and Therapeutic Vaccines), By Diagnostic Type (Serologic Test, Genetic Testing, and Small-Bowel Biopsy) By End-User (Hospitals and Diagnostics Centers, and Research Institutes) Forecast, 2021-2027

The global celiac disease market is predicted to grow at a CAGR of 8.5% during the forecast period. The market is projected to have impressive growth during the forecast period The increasing therapeutic product penetration in emerging economies, rising diabetes cases, increasing the number of clinical trials for drugs against celiac disease, and increasing gluten consumption, which leads to celiac disease, are the major factors for market expansion. For instance, according to the Center for Disease Control and Prevention, in 2020, there were around 34.2 million people have diabetes in the US which is 10.5% of the US population.

Furthermore, rising technical developments and expanding modernization in the healthcare sector, as well as rising research and development activities, would generate new chances for the celiac disease treatment market during the forecasted period. The global celiac disease market has seen a strong decline during the COVID-19 pandemic as celiac disease patients were highly at risk across the globe. Celiac disease is an autoimmune illness caused by a lack of tolerance for gluten, a protein found in or added to a variety of foods. The manufacturing industries have been halted their operations impacting the overall supply chain.

The global celiac disease market can be segmented based on treatment type, diagnostic type, and end-user. Based on the treatment type, the market is classified into vitamins and dietary (gluten-free) supplements, steroids, and immunosuppressive drugs, and therapeutic vaccines. Based on the diagnostic type, the market is classified into the serologic test, genetic testing, and small-bowel biopsy Apart from it, based on the end-user, the market is bifurcated into hospitals and diagnostics centers, and research institutes.

Geographically market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific is the fastest-growing market for the global celiac disease market due to the increased government expenditure along with patient awareness in countries like China and India. Besides, North America is growing due to an increase in demand for advanced treatment, and a high diagnosis rate in this region. However, the high cost of a gluten-free diet and a lack of patient information is limiting the celiac disease market's growth across the Middle East and Africa.

Research Methodology

The market study of the global celiac disease market is incorporated by extensive primary and secondary research conducted by the research team at OMR.  Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

Financial reports of companies involved in the market.

Whitepapers, research papers, and news blogs.

Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

Global Celiac Disease Market Research and Analysis by Treatment Type

Global Celiac Disease Market Research and Analysis by Diagnostic Type

Global Celiac Disease Market Research and Analysis by End-User

The Report Covers

Comprehensive research methodology of the global celiac disease market.

This report also includes a detailed and extensive market overview with key analyst insights.

An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.

Analysis of regional regulations and other government policies impacting the global celiac disease market.

Insights about market determinants that are stimulating the global celiac disease market.

Detailed and extensive market segments with the regional distribution of forecasted revenues.

Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Celiac DiseaseIndustry
  • Recovery Scenario of Global Celiac DiseaseIndustry
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Impact of COVID-19 on Key Players

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Celiac Disease Market by Treatment Type
    • 5.1.1. Vitamins and Dietary (Gluten-Free) Supplements
    • 5.1.2. Steroids and Immunosuppressive Drugs
    • 5.1.3. Therapeutic Vaccines
  • 5.2. Global Celiac Disease Market by Diagnostic Type
    • 5.2.1. Serologic Test
    • 5.2.2. Genetic Testing
    • 5.2.3. Small-Bowel Biopsy
  • 5.3. Global Celiac Disease Market by End-User
    • 5.3.1. Hospitals and Diagnostics Centers
    • 5.3.2. Research Institutes

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. South Korea
    • 6.3.5. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories
  • 7.2. AbbVie Inc.
  • 7.3. ADMA Biologics, Inc.
  • 7.4. Amgen Inc.
  • 7.5. Bayer AG
  • 7.6. Bio Rad Laboratories, Inc.
  • 7.7. BioLineRX Ltd.
  • 7.8. Boston Scientific Corp.
  • 7.9. Bristol-Myers Squibb Co.
  • 7.10. Calypso Biotech SA
  • 7.11. ChemoCentryx, Inc.
  • 7.12. Eli Lilly And Co.
  • 7.13. GlaxoSmithKline plc
  • 7.14. ImmunogenX, Inc.
  • 7.15. Janssen Pharmaceuticals, Inc.
  • 7.16. Johnson & Johnson Services Inc.,
  • 7.17. Merck & Co., Inc.,
  • 7.18. Sanofi S.A
  • 7.19. Thermo Fisher Scientific Inc.
  • 7.20. ZEDIRA GmbH

LIST OF TABLES

  • 1. GLOBAL CELIAC DISEASE MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
  • 2. GLOBAL CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
  • 3. GLOBALVITAMINS AND DIETARY SUPPLEMENTSFORCELIAC DISEASEMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 4. GLOBALSTEROIDS AND IMMUNOSUPPRESSIVE DRUGSFOR CELIAC DISEASEMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 5. GLOBALTHERAPEUTIC VACCINES FOR CELIAC DISEASEMARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 6. GLOBAL CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TYPE, 2020-2027 ($ MILLION)
  • 7. GLOBAL SEROLOGIC TESTIN CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 8. GLOBAL GENETIC TESTING IN CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 9. GLOBAL SMALL-BOWEL BIOPSY IN CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 10. GLOBAL CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 11. GLOBAL CELIAC DISEASE IN HOSPITALS AND DIAGNOSTICS CENTERS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 12. GLOBALCELIAC DISEASE INRESEARCH INSTITUTES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
  • 13. GLOBALCELIAC DISEASEMARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
  • 14. NORTH AMERICAN CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 15. NORTH AMERICAN CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
  • 16. NORTH AMERICAN CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TYPE, 2020-2027 ($ MILLION)
  • 17. NORTH AMERICAN CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 18. EUROPEAN CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 19. EUROPEAN CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
  • 20. EUROPEAN CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TYPE, 2020-2027 ($ MILLION)
  • 21. EUROPEAN CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 22. ASIA-PACIFIC CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 23. ASIA-PACIFIC CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
  • 24. ASIA-PACIFIC CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TYPE, 2020-2027 ($ MILLION)
  • 25. ASIA-PACIFIC CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
  • 26. REST OF THE WORLD CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
  • 27. REST OF THE WORLD CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2020-2027 ($ MILLION)
  • 28. REST OF THE WORLD CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY DIAGNOSTIC TYPE, 2020-2027 ($ MILLION)
  • 29. REST OF THE WORLD CELIAC DISEASE MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL CELIAC DISEASE MARKET, 2020-2027 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL CELIAC DISEASE MARKET BY SEGMENT, 2020-2027 ($ MILLION)
  • 3. RECOVERY OF GLOBAL CELIAC DISEASE MARKET, 2021-2027 (%)
  • 4. GLOBAL CELIAC DISEASE MARKET SHARE BY TREATMENT TYPE, 2020 VS 2027 (%)
  • 5. GLOBAL CELIAC DISEASE MARKET SHARE BY DIAGNOSTIC TYPE, 2020 VS 2027 (%)
  • 6. GLOBAL CELIAC DISEASE MARKET SHARE BY END-USER, 2020 VS 2027 (%)
  • 7. GLOBAL CELIAC DISEASE MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
  • 8. GLOBAL VITAMINS AND DIETARY SUPPLEMENTSFORCELIAC DISEASEMARKET SHARE BY REGION, 2020 VS 2027(%)
  • 9. GLOBAL STEROIDS AND IMMUNOSUPPRESSIVE DRUGS FOR CELIAC DISEASEMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 10. GLOBAL THERAPEUTIC VACCINESFOR CELIAC DISEASEMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 11. GLOBAL SEROLOGIC TESTIN CELIAC DISEASE MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 12. GLOBAL GENETIC TESTINGIN CELIAC DISEASE MARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 13. GLOBAL SMALL-BOWEL BIOPSY IN CELIAC DISEASEMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 14. GLOBALCELIAC DISEASE INHOSPITALS AND DIAGNOSTICS CENTERSMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 15. GLOBALCELIAC DISEASE INRESEARCH INSTITUTESMARKET SHARE BY REGION, 2020 VS 2027 (%)
  • 16. US CELIAC DISEASE MARKET SIZE, 2020-2027 ($ MILLION)
  • 17. CANADA CELIAC DISEASE MARKET SIZE, 2020-2027 ($ MILLION)
  • 18. UK CELIAC DISEASE MARKET SIZE, 2020-2027 ($ MILLION)
  • 19. FRANCE CELIAC DISEASE MARKET SIZE, 2020-2027 ($ MILLION)
  • 20. GERMANY CELIAC DISEASE MARKET SIZE, 2020-2027 ($ MILLION)
  • 21. ITALY CELIAC DISEASE MARKET SIZE, 2020-2027 ($ MILLION)
  • 22. SPAIN CELIAC DISEASE MARKET SIZE, 2020-2027 ($ MILLION)
  • 23. REST OF EUROPE CELIAC DISEASE MARKET SIZE, 2020-2027 ($ MILLION)
  • 24. INDIA CELIAC DISEASE MARKET SIZE, 2020-2027 ($ MILLION)
  • 25. CHINA CELIAC DISEASE MARKET SIZE, 2020-2027 ($ MILLION)
  • 26. JAPAN CELIAC DISEASE MARKET SIZE, 2020-2027 ($ MILLION)
  • 27. SOUTH KOREA CELIAC DISEASE MARKET SIZE, 2020-2027 ($ MILLION)
  • 28. REST OF THE ASIA-PACIFIC CELIAC DISEASE MARKET SIZE, 2020-2027 ($ MILLION)
  • 29. REST OF THE WORLD CELIAC DISEASE MARKET SIZE, 2020-2027 ($ MILLION)